Bioplus Life Sciences is a research driven company, continually evolving and aspires to improve products and service quality through the utilization of the latest technology combined with extensive research and experimentation on food ingredients and Nutraceutical products.
The technological and scientific expertise enables us to develop new and improved functional ingredients. The Research and Development’s (R&D’s) ability to explore the frontier science, to develop solutions for producing Active Ingredients in the Nutraceutical space, continues to advance our reputation as an emerging global player..
Our R&D team consists of well-experienced scientists from the best institutes in the country. The scientific talent pool is engaged in continuous interaction and participation with leading Universities and Institutions in technical programs to enable knowledge creation, and innovate in the related field of development.
Bioplus has a fully equipped Chemical Synthesis lab where the area of focus is mainly in Carbohydrate Chemistry, Functional Surfactants, Dendrimers and Natural products. The lab also consists of experts in the field of Ingredients purification using novel and latest technologies.
This lab is also involved in development of new products and intermediates, as per customer requirements with target timelines. The facility has a Kilo lab and a pilot plant where product scale up studies are carried out
The Biotech lab is equipped with facilities to handle microbial strains, develop products by microbial fermentation. Multiple lab fermenters (5L capacity) and pilot fermenters up to 500 L and Production fermenters up to 20 KL capacity are available in the Biotech facility.
The area of work is marine algal products, fungal and bacterial fermentation to produce Poly Unsaturated Fatty Acids (PUFA), Biopolymers and other related functional food ingredients.
The objective of formulation development is to develop generic drug products with emphasis on timely development of formulations for European (EU) and Rest of World (ROW) submissions. The focus of the department is to develop high quality generic products for a fast and smooth registration process and timely approval.
High quality, technology driven product development is carried out to produce a stable, clinically safe and effective formulation. A variety of dosage forms are being developed as powders (dispersible and orodispersible), tablets (conventional, chewable, dispersible, orodispersible, extended release, enteric coated etc.), capsules, ointments, creams, gels, suspensions, syrups, soft gelatin capsules and intravenous (IV) infusions.